...
首页> 外文期刊>Human Reproduction >Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy.
【24h】

Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy.

机译:米非司酮诱导的一氧化氮释放和早孕期间人宫颈中一氧化氮合酶的表达。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Nitric oxide (NO) is a factor in cervical ripening, perhaps under the control of progesterone. We studied the effects of the antiprogesterone mifepristone on the release of NO and on the expression of inducible NO synthase (iNOS) and endothelial NO synthase (eNOS) in the uterine cervix of women in early pregnancy. METHODS: Thirteen women were treated with oral mifepristone (200 mg), and 15 women were studied as controls. Cervical fluid samples were collected before treatment then hourly up to 3 h, and the samples were assayed for the concentration of nitric oxide metabolites (NOx). In addition, cervical biopsy samples from six women treated with mifepristone and from six controls were assessed for iNOS and eNOS by immunohistochemistry and Western blotting. RESULTS: In 1-3 h, mifepristone induced 7.4- to 17.2-fold elevations in cervical fluid NOx concentrations; no change was seen in the controls. The expression of both iNOS and eNOS was detected in the cervical cells. The expression of cervical iNOS was strong in five of the six women treated with mifepristone but was not strong in any of the six control women. CONCLUSION: This is the first study to show that mifepristone stimulates the release of NO and the expression of iNOS in cervical cells of women in early pregnancy. This may be one mechanism by which mifepristone initiates cervical ripening.
机译:背景:一氧化氮(NO)是宫颈成熟的一个因素,可能在孕酮的控制下。我们研究了抗孕激素米非司酮对妊娠早期妇女宫颈中NO的释放以及诱导型NO合酶(iNOS)和内皮型NO合酶(eNOS)表达的影响。方法:13名妇女接受口服米非司酮(200 mg)治疗,并以15名妇女作为对照。在治疗前收集子宫颈液样本,然后每小时进行一次直至3小时,然后分析样本中一氧化氮代谢产物(NOx)的浓度。此外,通过免疫组织化学和蛋白质印迹法评估了来自6名接受米非司酮治疗的妇女和来自6名对照的宫颈活检样品的iNOS和eNOS。结果:在1-3小时内,米非司酮引起宫颈液中NOx浓度升高7.4至17.2倍。控件中没有看到任何变化。在宫颈细胞中检测到iNOS和eNOS的表达。接受米非司酮治疗的六名女性中有五名宫颈iNOS的表达较强,但在六名对照女性中均未见高表达。结论:这是第一项表明米非司酮刺激妊娠早期妇女宫颈细胞中NO的释放和iNOS表达的研究。这可能是米非司酮启动子宫颈成熟的一种机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号